| Springhill Senior Residence | |
| 3717 Dauphin Street, Mobile, Alabama 36608 | |
| (251) 343-0909 | |
| Name | Springhill Senior Residence |
|---|---|
| Location | 3717 Dauphin Street, Mobile, Alabama |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 151 |
| Occupancy Rate | 46.62% |
| Medicare ID (CCN) | 015435 |
| Legal Business Name | Springhill Nursing Homes Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1770581654 |
| Organization Name | SPRINGHILL NURSING HOMES, INC |
| Doing Business As | SPRINGHILL SENIOR RESIDENCE |
| Address | 3717 Dauphin St, Mobile, AL 36608 |
| Phone Number | 251-343-0909 |
News Archive
A study published in the June issue of Anesthesiology has shown that a drug metabolite of the opioid morphine may be a key factor in the paradoxical increased sensitivity to pain caused by chronic morphine use. For the first time, this metabolite (called morphine-6 glucuronide, or M6G) was shown to act independently of the pain receptors typically targeted during morphine administration.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a grant from the National Institute of Health (NIH) to support the development of defensin-mimetic antimicrobial compounds for the treatment of malaria.
A new study reveals seventy-two novel genetic variants that are responsible for breast cancer risk. Published in the journals Nature and Nature Genetics, of these 72 variants, 65 are common variants that predispose patients to breast cancer and a further seven variants predispose particularly to estrogen -receptor negative breast cancer - the subcategory of cases that do not respond to hormonal treatments.
After 10 years in remission, Derek Ruff's cancer returned, this time as stage IV colon cancer. Despite aggressive rounds of chemotherapy, palliative radiotherapy and immunotherapy, his disease progressed.
New research has found children born in the last three months of the year in Melbourne may have a greater risk of developing respiratory diseases such as asthma.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A study published in the June issue of Anesthesiology has shown that a drug metabolite of the opioid morphine may be a key factor in the paradoxical increased sensitivity to pain caused by chronic morphine use. For the first time, this metabolite (called morphine-6 glucuronide, or M6G) was shown to act independently of the pain receptors typically targeted during morphine administration.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a grant from the National Institute of Health (NIH) to support the development of defensin-mimetic antimicrobial compounds for the treatment of malaria.
A new study reveals seventy-two novel genetic variants that are responsible for breast cancer risk. Published in the journals Nature and Nature Genetics, of these 72 variants, 65 are common variants that predispose patients to breast cancer and a further seven variants predispose particularly to estrogen -receptor negative breast cancer - the subcategory of cases that do not respond to hormonal treatments.
After 10 years in remission, Derek Ruff's cancer returned, this time as stage IV colon cancer. Despite aggressive rounds of chemotherapy, palliative radiotherapy and immunotherapy, his disease progressed.
New research has found children born in the last three months of the year in Melbourne may have a greater risk of developing respiratory diseases such as asthma.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 15.89 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.87 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 65.22 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.04 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 6.51 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.5 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.57 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 12.44 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.62 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 34.4 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 21.47 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 13.17 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 73.87 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 100 | 82.93 |
News Archive
A study published in the June issue of Anesthesiology has shown that a drug metabolite of the opioid morphine may be a key factor in the paradoxical increased sensitivity to pain caused by chronic morphine use. For the first time, this metabolite (called morphine-6 glucuronide, or M6G) was shown to act independently of the pain receptors typically targeted during morphine administration.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a grant from the National Institute of Health (NIH) to support the development of defensin-mimetic antimicrobial compounds for the treatment of malaria.
A new study reveals seventy-two novel genetic variants that are responsible for breast cancer risk. Published in the journals Nature and Nature Genetics, of these 72 variants, 65 are common variants that predispose patients to breast cancer and a further seven variants predispose particularly to estrogen -receptor negative breast cancer - the subcategory of cases that do not respond to hormonal treatments.
After 10 years in remission, Derek Ruff's cancer returned, this time as stage IV colon cancer. Despite aggressive rounds of chemotherapy, palliative radiotherapy and immunotherapy, his disease progressed.
New research has found children born in the last three months of the year in Melbourne may have a greater risk of developing respiratory diseases such as asthma.
› Verified 8 days ago
Allen Health And Rehabilitation Location: 735 South Washington Avenue, Mobile, Alabama 36603 Phone: (251) 433-2642 | |
Ashland Place Health And Rehabilitation, Llc Location: 148 Tuscaloosa St, Mobile, Alabama 36607 Phone: (251) 471-5431 | |
Azalea Health And Rehab Llc Location: 1758 Springhill Ave, Mobile, Alabama 36607 Phone: (251) 479-0551 | |
Little Sisters Of The Poor Sacred Heart Residence Location: 1655 Mcgill Avenue, Mobile, Alabama 36604 Phone: (251) 476-6335 | |
Twin Oaks Rehabilitation And Healthcare Center Location: 857 Crawford Lane, Mobile, Alabama 36617 Phone: (251) 476-3420 |